Medication info

Terbinafine Tablets (Terbinafine Hydrochloride)

Prescription medicationTabletExpired
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Independent BioPharmaceutical Co., Ltd.
Appearance
Round tablets, white to off-white in color
Packaging
For oral use - 30 tablets/bottle, For oral use - 100 tablets/bottle
Approval status
Expired

MFDS item code 201903598 · Approved 2019.05.31

This product's status changed to Expired on 2024.05.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of onychomycosis, dermatomycosis (such as tinea pedis), and tinea capitis in children
Who uses it
Adults · Children
Adult dosage
Administer 125 mg of terbinafine per dose twice daily, or 250 mg per dose once daily. The treatment duration varies according to the condition, as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment duration may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A treatment period of 3 months is usually sufficient for toenail infections, but in some patients it may take 6 months or longer. The treatment duration may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL per minute, reduce the daily dose by 1/2.
Children's dosage
Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with its use. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Independent BioPharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, dermatomycosis (such as tinea pedis), and tinea capitis in children

  • Athlete's foot
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medicine is used in adults for the treatment of dermatophytosis caused by dermatophytes, such as athlete's foot, tinea corporis, and tinea cruris, as well as onychomycosis. It is also effective for treating tinea capitis in children. In other words, it helps improve fungal infections present in the skin and nails.

Dosage and Administration

Adult dosage

Administer 125 mg of terbinafine per dose twice daily, or 250 mg per dose once daily. The treatment duration varies according to the condition, as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment duration may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A treatment period of 3 months is usually sufficient for toenail infections, but in some patients it may take 6 months or longer. The treatment duration may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL per minute, reduce the daily dose by 1/2.

Children's dosage

Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with its use. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be given regularly for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication is not recommended for patients with chronic liver disease or active liver disease. Liver function tests must be conducted before administration and periodically during treatment. If symptoms of liver dysfunction appear, discontinue the medication immediately and consult a physician. This medicine should not be administered to patients with blood disorders, severe renal failure, infants under 2 years old, or nursing mothers. Patients with certain genetic disorders should also avoid this medication. Exercise caution when using in patients with decreased kidney function, elderly individuals, or underweight children. If a severe rash or allergic reaction occurs, discontinue the medication immediately. This medicine can cause adverse reactions in various regions, including the liver, blood, skin, muscles, gastrointestinal tract, mental, and nervous systems, so consult medical personnel immediately if any unusual symptoms appear. Caution should be exercised while driving or operating machinery if dizziness occurs. There may be interactions with other medications, so be sure to inform your doctor or pharmacist of any other medications being taken. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and nursing mothers should cease breastfeeding while taking it. Special care should be taken when administering to children and the elderly, and in cases of overdose, immediate medical attention should be sought. Store this medication out of reach of children and keep it at room temperature, avoiding direct sunlight.

Side effects

Persistent nausea, decreased appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, loose stools, cholestatic liver insufficiency, hepatitis, bile stasis, jaundice, rash, skin itching, fever, nausea, vomiting, decreased appetite, lethargy, elevated liver enzymes, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, skin-mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, psoriasis exacerbation, hair loss, musculoskeletal reaction, arthralgia, myalgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, gastrointestinal symptoms, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, upper abdominal discomfort, thirst, vomiting, glossitis, depression, anxiety disorder, headache, taste disorder, dizziness, drowsiness, sensory disturbances, sensory loss, decreased attention, insomnia, elevated BUN, polyuria, visual disturbances, tinnitus, anaphylactic reactions, angioedema, systemic lupus erythematosus, elevated serum total cholesterol, increased triglyceride levels, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reactions, serum sickness-like reactions, blurred vision, decreased visual acuity, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase levels, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent air or moisture from entering. It is best stored at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Round tablets, white to off-white in color

Package unit

For oral use - 30 tablets/bottle, For oral use - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.